These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9216132)

  • 21. Hemodynamic effects of arbutamine.
    Ogilby JD; Molk B; Iskandrian AE
    Am J Cardiol; 1998 Sep; 82(5):699-702, A9. PubMed ID: 9732911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model reference adaptive control with constraints for postoperative blood pressure management.
    Pajunen GA; Steinmetz M; Shankar R
    IEEE Trans Biomed Eng; 1990 Jul; 37(7):679-87. PubMed ID: 2394456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between gender and clinical management after exercise stress testing.
    Daugherty SL; Peterson PN; Magid DJ; Ho PM; Bondy J; Hokanson JE; Ross CA; Rumsfeld JS; Masoudi FA
    Am Heart J; 2008 Aug; 156(2):301-7. PubMed ID: 18657660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography. International Arbutamine Study Group.
    Bach DS; Armstrong WF
    Am J Cardiol; 1995 Aug; 76(4):259-62. PubMed ID: 7618620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ephedrine increases ventricular arrhythmias in conscious dogs after myocardial infarction.
    Adamson PB; Suarez J; Ellis E; Kanaly T; Vanoli E
    J Am Coll Cardiol; 2004 Oct; 44(8):1675-8. PubMed ID: 15489103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes.
    Johansen OE; Bjurö T; Endresen K; Blaasaas KG; Birkeland K; Aakhus S; Gullestad L
    Int J Cardiol; 2008 Jun; 127(1):129-32. PubMed ID: 17532067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arbutamine stress echocardiography.
    Ketteler T; Krahwinkel W; Wolfertz J; Gödke J; Hoffmeister T; Scheuble L; Gülker H
    Eur Heart J; 1997 Jun; 18 Suppl D():D24-30. PubMed ID: 9183607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and diagnostic utility of arbutamine for cardiovascular stress testing during echocardiographic monitoring.
    Armstrong WF; Bach DS
    Eur Heart J; 1995 Nov; 16 Suppl M():24-7. PubMed ID: 8869120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine infusion--poor alternative as stress test.
    Kaushal SS; Dasgupta DJ; Prashar BS; Bhardwaj P; Bhardwaj R; Sood Y
    J Assoc Physicians India; 1994 Apr; 42(4):344-5. PubMed ID: 7860570
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in Pharmacological Cardiac Stress Testing: Arbutamine Closed-Loop Feedback System.
    Crouse L
    Echocardiography; 1998 May; 15(4):393-400. PubMed ID: 11175055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intelligent automated drug administration and therapy: future of healthcare.
    Sharma R; Singh D; Gaur P; Joshi D
    Drug Deliv Transl Res; 2021 Oct; 11(5):1878-1902. PubMed ID: 33447941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiscale modeling of cardiac cellular energetics.
    Bassingthwaighte JB; Chizeck HJ; Atlas LE; Qian H
    Ann N Y Acad Sci; 2005 Jun; 1047():395-424. PubMed ID: 16093514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative physiological study of arbutamine with exercise in humans.
    Lovell SL; Maguire SM; Turtle F; McDowell G; Campbell NP; Riley MS; Nicholls DP
    Clin Sci (Lond); 2000 Apr; 98(4):489-94. PubMed ID: 10731485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of computerized closed-loop delivery of arbutamine: a new pharmacologic myocardial stress modality for the assessment of coronary artery disease. The European Arbutamine Study Group.
    Cramer MJ; Jaarsma W; Sutherland GR; Nihoyannopoulos P; Fioretti P; Tan LB; Schröder K; Visser CA
    J Am Soc Echocardiogr; 1995; 8(6):854-63. PubMed ID: 8611285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using physiologic and pharmacologic stress testing in the evaluation of coronary artery disease.
    Meyer N
    Nurse Pract; 1999 Apr; 24(4):70-2, 75-6, 78 passim. PubMed ID: 10234689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closed-loop drug infusion for control of heart-rate trajectory in pharmacological stress tests.
    Valcke CP; Chizeck HJ
    IEEE Trans Biomed Eng; 1997 Mar; 44(3):185-95. PubMed ID: 9216132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arbutamine stress testing with closed-loop drug delivery. Toward the ideal or just another pharmacologic stress technique?
    Marwick TH
    J Am Coll Cardiol; 1995 Nov; 26(5):1176-9. PubMed ID: 7594029
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.